BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27690720)

  • 1. Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility.
    Lakhi NA; Mizejewski GJ
    Fetal Pediatr Pathol; 2017 Feb; 36(1):49-61. PubMed ID: 27690720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Fanconi anemia/BRCA genes in zebrafish sex determination.
    Rodríguez-Marí A; Postlethwait JH
    Methods Cell Biol; 2011; 105():461-90. PubMed ID: 21951543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of a FANCE Splice Isoform in Regard to DNA Repair.
    Bouffard F; Plourde K; Bélanger S; Ouellette G; Labrie Y; Durocher F
    J Mol Biol; 2015 Sep; 427(19):3056-73. PubMed ID: 26277624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Boolean network model of the FA/BRCA pathway.
    Rodríguez A; Sosa D; Torres L; Molina B; Frías S; Mendoza L
    Bioinformatics; 2012 Mar; 28(6):858-66. PubMed ID: 22267503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fanconi anemia and breast cancer susceptibility.
    Patel KJ
    Nat Genet; 2007 Feb; 39(2):142-3. PubMed ID: 17262024
    [No Abstract]   [Full Text] [Related]  

  • 7. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.
    García MJ; Fernández V; Osorio A; Barroso A; Fernández F; Urioste M; Benítez J
    Carcinogenesis; 2009 Nov; 30(11):1898-902. PubMed ID: 19737859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
    Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Finnish Fanconi anemia mutations and hereditary predisposition to breast and prostate cancer.
    Mantere T; Haanpää M; Hanenberg H; Schleutker J; Kallioniemi A; Kähkönen M; Parto K; Avela K; Aittomäki K; von Koskull H; Hartikainen JM; Kosma VM; Laasanen SL; Mannermaa A; Pylkäs K; Winqvist R
    Clin Genet; 2015 Jul; 88(1):68-73. PubMed ID: 24989076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new frontier in Fanconi anemia: From DNA repair to ribosome biogenesis.
    Gueiderikh A; Maczkowiak-Chartois F; Rosselli F
    Blood Rev; 2022 Mar; 52():100904. PubMed ID: 34750031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins.
    Wang W
    Nat Rev Genet; 2007 Oct; 8(10):735-48. PubMed ID: 17768402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2.
    Godthelp BC; Wiegant WW; Waisfisz Q; Medhurst AL; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Feb; 594(1-2):39-48. PubMed ID: 16154163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome Instability in Fanconi Anemia: From Breaks to Phenotypic Consequences.
    García-de-Teresa B; Rodríguez A; Frias S
    Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33371494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SnapShot: Fanconi anemia and associated proteins.
    Wang AT; Smogorzewska A
    Cell; 2015 Jan; 160(1-2):354-354.e1. PubMed ID: 25594185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired removal of DNA interstrand cross-link in Nijmegen breakage syndrome and Fanconi anemia, but not in BRCA-defective group.
    Tsuchida K; Komatsu K
    Cancer Sci; 2008 Nov; 99(11):2238-43. PubMed ID: 18771529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2.
    Hussain S; Wilson JB; Blom E; Thompson LH; Sung P; Gordon SM; Kupfer GM; Joenje H; Mathew CG; Jones NJ
    DNA Repair (Amst); 2006 May; 5(5):629-40. PubMed ID: 16621732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular basis of Fanconi's anemia].
    Digweed M
    Klin Padiatr; 1999; 211(4):192-7. PubMed ID: 10472548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fanconi anemia: at the crossroads of DNA repair.
    Deakyne JS; Mazin AV
    Biochemistry (Mosc); 2011 Jan; 76(1):36-48. PubMed ID: 21568838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update of the human and mouse Fanconi anemia genes.
    Dong H; Nebert DW; Bruford EA; Thompson DC; Joenje H; Vasiliou V
    Hum Genomics; 2015 Nov; 9():32. PubMed ID: 26596371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.